Comparative Proteome and Serum Analysis Identified FSCN1 as a Marker of Abiraterone Resistance in Castration-Resistant Prostate Cancer

Investigators identified baseline Fascin-1 (FSCN1) serum levels to be independently associated with poor survival of Abi-treated, but not docetaxel-treated mCRPC patients.